Navigation Links
Genomma Lab Announces the Successful Launch of the Ma Evans Brand
Date:12/11/2008

MEXICO CITY, Dec. 11 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), a leading Mexican over-the-counter ("OTC") pharmaceuticals and personal care products company announced today the successful launch of the personal hair care product line Ma Evans. The product launch was realized through a mass media campaign under the brand name "Ma Evans Evolution". The Company has been successful in placing the product in the market through its distribution channels. In addition, the product has been well-received at the point of sale, and has surpassed initial sales objectives. The product launch contains five SKU's in the anti-hair loss shampoo, anti-hair loss treatment and hair gel categories.

The Ma Evans brand was acquired by Genomma Lab during the fourth quarter 2007 due to its high level of brand recognition in the shampoo and anti-hair loss treatment categories. With this launch, Genomma Lab reinforces its presence in the hair care category, in which it currently participates under the anti-dandruff shampoo brand Medicasp. The market size of the Mexican hair care category is approximately Ps. 15 billion pesos(1).

With this launch, Genomma Lab confirms its capacity to acquire, transform and re-launch brands focused on the target consumer's likes and preferences.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab performed its Initial Public Offering in June, 2008, through a combined offering (mainly primary) and is listed on the Mexican Stock Exchange under the ticker symbol "LAB" (Bloomberg:
'/>"/>

SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genomma Lab Announces 2009 Earnings Guidance
2. Genomma Lab Internacional Acquires UNIGASTROZOL
3. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
4. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
5. iSirona Announces New President and Chief Sales Officer
6. Misonix Announces Extension and Expansion of Distribution Agreement With Mentor Corporation
7. WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development
8. Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals
9. Markel Corporation Announces New DataBreach(SM) Privacy Liability Coverage
10. Allscripts Announces Expiration of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024
11. Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 2Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 3Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 4Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 5Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 6Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 7Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 8Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 9Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 10Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 11Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 12Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 13Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 14Health News:Practice Greenhealth Hires First Exec 2Health News:Gerresheimer Starts the Year Successfully in 2008 2Health News:Gerresheimer Starts the Year Successfully in 2008 3Health News:Gerresheimer Starts the Year Successfully in 2008 4Health News:Northwest Songwriter Dean Backholm Featured on National March of Dimes CD 2Health News:Kent State University Stark Campus to Confer First Class of Nursing Students 2Health News:Clergy Abuse Victims Want UN to Investigate Vatican 2
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 1Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 2Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 4Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 5Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 6President Obama Misleads on Abortion Funding in Health Care Reform 54931 1President Obama Misleads on Abortion Funding in Health Care Reform 54931 2Kaiser Workers Launch Statewide Pickets 54929 1